LICOSER 30 TABLETS

  • BREA Srl
  • 905353621

Food supplement based on Serenoa repens, lycopene, zinc, vitamin E, useful for filling deficiencies in case of increased needs or reduced intake with the diet. It can be used as an adjunct in maintaining the physiological properties of the prostate gland.

info_outline View product sheet
Final Price €21.50
Quantity
check_circle Available
Shipped within 24 h
  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Supplements Others products at unbeatable price

LICOSER 30 TABLETS

LICOSER

Food supplement based on Serenoa repens, lycopene, zinc, vitamin E, useful to fill the deficiencies in case of increased needs or reduced intake with the diet. It can be used as an adjunct in maintaining the physiological properties of the prostate gland.
Serenoa Repens (synonym of Sabal Serrulata)
Plant widespread in the United States, Southern Europe and North Africa. The most important chemical constituents are different sterols, free fatty acids, carotenoids, essential oils and polysaccharides.
Useful for the proper functioning of the urinary tract and prostate.
Lycopene
Natural pigment belonging to the class of carotenoids, it is characterized by antioxidant properties similar to those of beta-carotene, but is much more powerful, therefore much more effective in preventing free radical damage than oxygen. In nature, Lycopene is present in tomatoes and other vegetable substances; endowed with high antioxidant activity, it is considered among the carotenoids the most powerful "scavanger" (scavenger) of oxygen free radicals.
Urtica Dioica
Perennial herbaceous plant, native to western Asia, widespread in all temperate regions, including Italy. In modern phytotherapy the root plays a leading role, in fact it is rich in phytosterols (α-sitosterol, daucosterol and related glucosides), with a mechanism of action similar to those of Serenoa but also contains lecithins (scopoletin) which inhibit the EGF (Epidermal Grow Factor) a cell growth factor capable of reducing symptoms and partially also the volume of the gland. Therefore, the Urtica Dioica root extract is particularly beneficial for limiting the growth of prostate tissue induced by androgens and in particular by dihydrotestosterone.
Green tea
It is obtained from the buds of the leaves and from the young leaves of the plant known with the scientific name of "Camelia sinensis". The peculiarity of this plant is given by its high antioxidant potential.
It does not contain gluten or sugars.

Ingredients

  for 1 tablet
(1200 mg)
Serenoa repens (e.g. 30% total fatty acids) 320 mg
Lycopene 8 mg
Zinc 11.25 mg
Vitamin E 15 mg


How to use

The treatment involves taking 1 - 2 tablets per day for a period of at least 6 - 12 months.
It can be taken indifferently at any time of day and indifferently during meals or between meals.

Warnings
Do not exceed the recommended daily dose. Keep out of the reach of children under 3 years of age. Supplements are not intended as a substitute for a varied diet. For pregnant or lactating women and children it is recommended to seek medical advice.

Format
Pack of 30 tablets.

Cod.1010007.

Bibliography
- Carilla E, Briley M, Fauran F, Sultan C, Duvilliers C. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem 1984; 20: 521-3.
- Champault G, Patel JC, Bonnard QAM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol 1984; 18: 461-2.
- De Bruyne F. et al. Evaluation of the clinical benefit Serenoa Repens and Tamsulosin in severe BPH patients-Personal study subset analysis.Eur.Urol. 2004 Jun; 45 (6): 773-9; Discussion 779-80,2004.
- Boyle P, Robertson C, lowe F, Roehrborn C. Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia.Urology 2000; 55: 533-9.
- Bent S. et al. Saw Palmetto for benign prostatic hyperplasya. N.Engl.J. Med. 354 (6): 557-66.2006.
- Wilt T, Ishani A, Stark G, Mac donald R, Mulrow C, Lau J. Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev 2000; 2: CD001423.
- Fong YK, Milani S, Djavan B, Role of phytotherapy in men with lower urinary tract symptoms. Curr opin urol. 2005; 15 (1); 45-48.
- Wilt T, Ishani A, Mac Donald R, Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2002; 3; CDCD001423.
- Strauch G, Perles P, Vergult G, et al. Comparison of finasteride and Serenoa repens in the inhibition of 5-alpha reductase in healthy male volunteers. Eur.Urology 1994; 26: 3, 247-252.
- Debruyne F, Boyle P, Calais da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela- Navarrete R, Raynaud JP, Schulman C, Evalutation of the clinical benefit of permixon and tamsulosin in severe BPH patiens- PERMAL study subset analysis. Prog Urol, 2004 Jun; 14 (3): 326-331.
- Avins AL et al. A detailed safety assestment of a Saw Palmetto extract. Complement ther med. 16 (3): 147-154.2008.
- Levy J., Bosin E. Et al., Lycopene is a more potent inhibitor of human cancer cell proliferation than eitherv a-carotene or b-carotene. Cancer, 1995; 24: 257-266.
- Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU int 200; 86 (4): 439-442.
- Schneider T, Rubben H, Stinging nettle root extract in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months. Urologe A, 2004; 43 (3): 302-306.
- Lichius JJ, The inhibiting effects of components of stinging nettle roots on experimentally induced prostatic i hyperplasia in mice. Planta Med, 1999; 65, 7: 666-668.
- Bombardelli E, Morazzoni P, Urtica Dioica L. Phytotherapy 1997; 68.5, 387-402.
- Chem Pharm, Bulletin 38-1990.
- Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, Japan Public Health Center- Based Prospective Study Group. Dairy product, satured fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev, 2008 Apr; 17 (4): 930-937.
- Betuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof -of-principle study. cancer Res, 2006 Jan 15; 66 (2): 1234-1240.
- Etminan M, Takkouche B, Caamano-Isorna F The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev, 2004 Mar; 13 (3): 340-345.
- Michael B. Sporn and Karen T. Liby Is Lycopene an effective Agent for preventing prostate cancer? Cancer Prevention Research 14-03-2013.

BREA Srl
905353621
chat Comments (0)